Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
Colestid granules for oral suspension 5 g.
| Pharmaceutical Form |
|---|
|
Granules for oral suspension. Light yellow, tasteless and odourless granules. |
Each level scoopful or sachet contains 5 g of colestipol hydrochloride.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Colestipol |
Colestipol is an ion exchange resin which lowers plasma cholesterol through binding with bile acids in the intestinal lumen. It is indicated as adjunctive therapy to diet in the management of patients with elevated cholesterol levels who have not responded adequately to diet. |
| List of Excipients |
|---|
|
Colloidal anhydrous silica |
Paper/Aluminium foil/vinyl sachets of 5 g (in packs of 10 or 30 sachets).
Pack size: 5 g.
Amber glass bottle with screw cap or HDPE bottle with screw cap or tamper-evident cap.
Pack size: 250 g.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 00057/0950
Date of first authorisation: 26 October 1992
Date of latest renewal: 16 June 2010
| Drug | Countries | |
|---|---|---|
| COLESTID | Canada, Estonia, Spain, Israel, New Zealand, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
